• OPEN ACCESS

Journal of Clinical and Translational Hepatology Receives Its First Impact Factor (4.108) and CiteScore (6.7)

  • Harry Hua-Xiang Xia1 ,
  • George Y. Wu2 and
  • Hong Ren3,* 
 Author information
Journal of Clinical and Translational Hepatology 2021;9(4):453-453

DOI: 10.14218/JCTH.2021.ANNOUNCE

Abstract

Keywords

We are pleased to announce that Journal of Clinical and Translational Hepatology (JCTH) has received its first impact factor – 4.108 – in the Journal Citation Report released by Clarivate Analytics on June 30, 2021. JCTH now ranks 42nd among 92 journals in the Gastroenterology and Hepatology category and is in the second quartile (Q2) in the category (Fig. 1). Moreover, JCTH has also received its first CiteScore – 6.7 – released by Elsevier on June 4, 2021 and ranks 16th among 62 hepatology journals according to that evaluation system (Fig. 2).

Impact factor 2020 of <italic>Journal of Clinical and Translational Hepatology</italic> (From Web of Science, Clarivate Analytics).
Fig. 1  Impact factor 2020 of Journal of Clinical and Translational Hepatology (From Web of Science, Clarivate Analytics).
CiteScore 2020 of <italic>Journal of Clinical and Translational Hepatology</italic> (From Scopus, Elsevier).
Fig. 2  CiteScore 2020 of Journal of Clinical and Translational Hepatology (From Scopus, Elsevier).

JCTH, which is owned by the Second Affiliated Hospital of Chongqing Medical University and published by Xia & He Publishing Inc., publishes articles on both basic and clinical liver disease research. The translational application of basic science is a distinctive feature of the Journal. JCTH was launched in 2013 and has been included in PubMed Central and PubMed since July 2015, in Scopus since May 2020, and in SCIE since November 2020.1

We would like to take this opportunity to express our heartfelt gratitude to our staff, associate editors, editorial board members, early-career editors, reviewers, authors, and readers, for their dedication, contributions, and attention to the Journal.

Having the first impact factor being over 4 and CiteScore being 6.7 is encouraging and inspiring. However, we recognize these achievements as representing a solid foundation from which we will continue to push forth our efforts toward greater academic goals. In these efforts, we will continue to be rigorous in both academic quality and ethical standards, ever-striving to bring timely research findings in hepatology to the scientific community as an internationally influential journal.

References

  1. Xia HHX, Wu GY, Ren H. Journal of Clinical and Translational Hepatology has been indexed in SCIE: a milestone towards a greater academic goal. J Clin Transl Hepatol 2020;8(4):357-358 View Article PubMed/NCBI
  • Journal of Clinical and Translational Hepatology
  • pISSN 2225-0719
  • eISSN 2310-8819
  • Copyright © 2022 JCTH. All Rights Reserved.
  • Published by Xia & He Publishing Inc.
  • Address: 14090 Southwest Freeway, Suite 300, Sugar Land, Texas 77478, USA
  • Email: service@xiahepublishing.com